Nevoid melanoma

Nevoid describes a resemblance

Nevoid melanoma includes melanomas resembling a benign nevus clinically and especially histologically. The term, introduced into specialist literature by Schmoeckel and colleagues, describes a recognition problem rather than a guarantee of benign behaviour.

It does not necessarily mean the tumour developed by transformation of a pre-existing mole. Origin within a nevus and a nevoid appearance are different findings; many melanomas arise on skin without a previously recognised mole. General estimates of nevus-associated melanomas are not a specific percentage for the nevoid variant.

Clinical appearance and dermoscopy

It may appear as a relatively regular papule or nodule, dome-shaped or warty, brown or variably pigmented. The trunk and limbs are reported sites but are not exclusive. Mean age, male predominance and a size around one centimetre in some series are not required diagnostic criteria.

A new or changing lesion deserves attention even when symmetrical. Brown, black, bluish, reddish or pale areas may occur, but no colour combination is mandatory. Dermoscopy contributes to assessment without replacing tissue sampling when indicated.

The ABCDE rule and attention to evolution help identify changes. An atypical presentation can escape a rigid interpretation of those rules. Earlier photographs and clinical history provide useful information for the specialist.

Why it can be mistaken for a nevus

Tissue may contain nests of melanocytic cells with a deceptively reassuring arrangement and a dome-shaped or warty outline. Lateral boundaries may be distinct while the deep component is less well defined. These features are not identical in every case.

The pathologist assesses atypia, mitoses, maturation with depth and the relationship between epidermal and dermal components. Junctional activity may be limited but is not always absent. Epithelioid and smaller cells can overlap with dermal nevi and small cell melanoma.

Histological examination needs representative tissue. Immunohistochemistry and, when necessary, molecular analysis or expert review help resolve difficult cases. No single marker replaces architecture, cytology and clinical context together.

Treatment, recurrence and follow-up

Once diagnosis is confirmed, management follows the site and stage of melanoma. Breslow thickness, ulceration and margins guide surgery and discussion of sentinel lymph node biopsy. Systemic options depend on risk, spread and biological features.

Recurrence and metastasis have been described, but “nevoid” alone cannot estimate prognosis. Diagnostic delay can have consequences; correct classification allows appropriate care. Keep the pathology report and ask for clarification if clinical and tissue diagnoses appear discordant.

Skin self-examination should include apparently ordinary lesions. Report persistent growth or change without waiting for a mole to become very dark, painful or irregular.